Vaginal cancer incidence statistics

Cases

New cases of vaginal cancer, 2015, UK

 

Proportion of all cases

Percentage vaginal cancer is of total cancer cases, 2015, UK

 

Age

Peak rate of vaginal cancer cases, 2013-2015, UK

Trend over time

Vaginal cancer incidence rates have remained stable since the early 1990s, UK

Vaginal cancer is not among the 20 most common cancers in females in the UK, accounting for less than 1% of all new cancer cases in females (2015).[1-4]

Vaginal cancer incidence rates (European age-standardised (AS) rates Open a glossary item ) are significantly lower than the UK average in Wales, and similar to the UK average in all other UK constituent countries.

Vaginal Cancer (C52), Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Females, UK, 2015

  England Scotland Wales Northern Ireland UK
Female Cases 197 21 6 8 232
Crude Rate 0.7 0.8 0.4 0.8 0.7
AS Rate 0.7 0.8 0.3 0.9 0.7
AS Rate - 95% LCI 0.6 0.4 0.1 0.3 0.6
AS Rate - 95% UCI 0.8 1.1 0.6 1.5 0.8
Persons Cases 197 21 6 8 232
Crude Rate 0.4 0.4 0.2 0.4 0.4
AS Rate 0.4 0.4 0.2 0.5 0.4
AS Rate - 95% LCI 0.3 0.2 0.0 0.2 0.3
AS Rate - 95% UCI 0.4 0.6 0.3 0.9 0.4

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item  around the AS Rate Open a glossary item
 

For vaginal cancer, like most cancer types, differences between countries largely reflect risk factor prevalence in years past.

References

  1. Data were provided by the Office for National Statistics on request, July 2017. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases.
  2. Data were provided by ISD Scotland on request, August 2017. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, October 2017. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, July 2017. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2015, ICD-10 C52.

Last reviewed:

Vaginal cancer incidence is strongly related to age, with the highest incidence rates being in older women. In the UK in 2013-2015, on average each year almost 4 in 10 (38%) of new cases were in females aged 75 and over.[1-4

Age-specific incidence rates rise steadily from around age 30-34 and more steeply from around age 45-49. The highest rates are in the 80 to 84 age group.

Vaginal Cancer (C52), Average Number of New Cases per Year and Age-Specific Incidence Rates per 100,000 Population, Females, UK, 2013-2015

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS Rate Open a glossary item
 

For vaginal cancer, like most cancer types, incidence increases with age. This largely reflects cell DNA damage accumulating over time. Damage can result from biological processes or from exposure to risk factors. A drop or plateau in incidence in the oldest age groups often indicates reduced diagnostic activity perhaps due to general ill health.

References

  1. Data were provided by the Office for National Statistics on request, July 2017. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases.
  2. Data were provided by ISD Scotland on request, August 2017. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, October 2017. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, July 2017. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2013-2015, ICD-10 C52.

Last reviewed:

Vaginal cancer European age-standardised (AS) Open a glossary item incidence rates for females remained stable in the UK between 1993-1995 and 2013-2015.[1-4].

Over the last decade in the UK (between 2003-2005 and 2013-2015), vaginal cancer AS incidence rates for females remained stable.[1-4]

Vaginal Cancer (C52), European Age-Standardised Incidence Rates, Females, UK, 1993-2015

Vaginal cancer incidence rates have remained stable overall in all broad adult age groups in females in the UK since the early 1990s.[1-4] Rates in 25-49s have remained stable, in 50-59s have remained stable, in 60-69s have remained stable, in 70-79s have remained stable, and in 80+s have remained stable.

Vaginal Cancer (C52), European Age-Standardised Incidence Rates, By Age, Females, UK, 1993-2015

For vaginal cancer, like most cancer types, incidence trends largely reflect changing prevalence of risk factors and improvements in diagnosis and data recording. Recent incidence trends are influenced by risk factor prevalence in years past, and trends by age group reflect risk factor exposure in birth cohorts.

References

  1. Data were provided by the Office for National Statistics on request, July 2017. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases.
  2. Data were provided by ISD Scotland on request, August 2017. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
  3. Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, October 2017. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
  4. Data were provided by the Northern Ireland Cancer Registry on request, July 2017. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 1993-2015, ICD-10 C52

Last reviewed:

More than 90% of primary tumours Open a glossary item in the vagina are carcinomas Open a glossary item, and, of these, almost 80% are squamous cell carcinoma [glossary - squamous cell cancer] and about 14% are adenocarcinomas Open a glossary item. [1,2] Adenocarcinomas are more common in childhood and early adulthood, accounting for the vast majority of carcinomas diagnosed in women under 20.[1,2] A small proportion of adenocarcinomas are clear cell carcinomas arising in women exposed to diethylstilboestrol (DES) in utero. The highest incidence of clear cell carcinoma arises in young women in their late teens and early 20s.[3] Melanomas and sarcomas account for about 7% of primary vaginal tumours.[1]

References

  1. Creasman WT, Phillips JL, Menck HR. The National cancer data base report on cancer of the vagina. Cancer 1998; 83:1033.
  2. Beller U, Sideri M, Maisonneuve P, et al. Carcinoma of the vagina. Int J Gynaecol Obstet 2003; 83 Suppl 1:27-39.
  3. Laitman CJ. DES exposure and the aging woman: mothers and daughters. Curr Womens Health Rep 2002; 2(5):390-3.
Last reviewed:

The lifetime risk of developing vaginal cancer is around 1 in 1,270 for women, in 2012 in the UK.[1]

The lifetime risk for vaginal cancer has been calculated on the assumption that the possibility of having more than one diagnosis of vaginal cancer over the course of a lifetime is very low (‘Current Probability’ method).[2]

References

  1. Lifetime risk estimates calculated by the Statistical Information Team at Cancer Research UK. Based on data provided by the Office of National Statistics, ISD Scotland, the Welsh Cancer Intelligence and Surveillance Unit and the Northern Ireland Cancer Registry, on request, December 2013 to July 2014.
  2. Esteve J, Benhamou E and Raymond L. Descriptive epidemiology. IARC Scientific Publications No.128, Lyon, International Agency for Research on Cancer, pp 67-68 1994.
Last reviewed:

There is evidence for an association between vaginal cancer incidence and deprivation in England.[1] England-wide data for 2006-2010 show European age-standardised Open a glossary item incidence rates are 85% higher for females living in the most deprived areas compared with the least deprived.[1]

Vaginal Cancer (C52), European Age-Standardised Incidence Rates by Deprivation Quintile, Females, England, 2006-2010

The estimated deprivation gradient in vaginal cancer incidence between females living in the most and least deprived areas in England has not changed in the period 1996-2010.[1] It has been estimated that there would have been 50 fewer cancer cases each year in England during 2006-2010 if all females experienced the same incidence rates as the least deprived.[1]

References

  1. Cancer Research UK and National Cancer Intelligence Network. Cancer by deprivation in England: Incidence, 1996-2010, Mortality, 1997-2011. London: NCIN; 2014.

About this data

Data is for UK, 2006-2010, ICD-10 C52

Deprivation gradient statistics were calculated using incidence data for 2006-2010. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Donate online

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.

Rate this page:

Currently rated: 1.5 out of 5 based on 8 votes
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page